쉬운공시
올릭스 기타경영사항(특허권취득)(자율공시)(TREATMENT OF ANGIOGENESIS-ASSOCIATED DISEASES USING RNA COMPLEXES THAT TARGET ANGPT2 AND PDGFB) | 쉬운공시